ATS 2020: Meta-Analysis of Dupilumab Trials Offers Indirect Comparison With Anti-Interleukin-5 Biologics
Benefits with dupilumab were particularly notable regarding improvement in lung function
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.